Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISANKIZUMAB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

51.3%
Female
48.7%
Male

Age Information

The average age of patients reporting adverse events with RISANKIZUMAB is 52.1 years.

Geographic Distribution

The majority of adverse event reports for RISANKIZUMAB originate from US.

Report Summary & Outcomes

2,642
Total Reports
2,642
As Primary/Secondary Suspect
41
Deaths Reported
439
Hospitalizations
23
Life-Threatening
19
Disabilities

Reporting Timeline

First adverse event report: 20070101. Most recent report: 20250923. View full timeline →

More About RISANKIZUMAB

RISANKIZUMAB Full Profile Reports by Year Drug Interactions